| Literature DB >> 34986677 |
Xing Liu1, Abai Xu1, Jingwen Huang1, Haiyan Shen1, Yazhen Liu1.
Abstract
OBJECTIVE: To begin to understand how to prevent deep vein thrombosis (DVT) after an innovative operation termed intracorporeal laparoscopic reconstruction of detenial sigmoid neobladder, we explored the factors that influence DVT following surgery, with the aim of constructing a model for predicting DVT occurrence.Entities:
Keywords: Intracorporeal laparoscopic reconstruction of detenial sigmoid neobladder; bladder cancer; deep vein thrombosis; disease prediction model; protective factor; risk factor
Mesh:
Year: 2022 PMID: 34986677 PMCID: PMC8753248 DOI: 10.1177/03000605211067688
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Univariate analysis of all factors.
| Group | Patients with DVT (cases, | Patients without DVT (controls, |
|
|
|---|---|---|---|---|
| Age | 61.29 ± 10.31 | 70.19 ± 8.46 | −3.319 | 0.001* |
| Sex | 0.173 | 0.677 | ||
| Male | 126 (94.03) | 16 (100.00) | ||
| Female | 8 (5.97) | 0 (0.00) | ||
| BMI | ||||
| <18.5 | 12 (8.96) | 0 (0.00) | 0.578 | 0.447 |
| 18.5–23.9 | 70 (52.24) | 11 (68.75) | 1.569 | 0.210* |
| 24.0–27.9 | 44 (32.84) | 3 (18.75) | 1.318 | 0.251 |
| >28 | 8 (5.97) | 2 (12.50) | 0.211 | 0.646 |
| Smoking history | 2.866 | 0.259 | ||
| Non-smoker | 109 (80.74) | 14 (87.50) | 0.101 | 0.751 |
| Ex-smoker | 2 (1.48) | 1 (6.25) | 0.119 | 0.730 |
| Smoker | 24 (17.78) | 1 (6.25) | 0.668 | 0.414 |
| History of DVT | 0.000 | 1.000 | ||
| No | 134 (99.26) | 16 (100.00) | ||
| Yes | 1 (0.74) | 0 (0.00) | ||
| Family history of DVT | / | / | ||
| No | 135 (100.00) | 16 (100.00) | ||
| Yes | 0 (0.00) | 0 (0.00) | ||
| Hemostatic drugs (somatostatin, thrombin, etc.) | 8.899 | 0.003* | ||
| No | 49 (36.30) | 12 (75.00) | ||
| Yes | 86 (63.70) | 4 (25.00) | ||
| Anticoagulant drug | 0.000 | 1.000 | ||
| No | 34 (25.19) | 4 (25.00) | ||
| Yes | 101 (74.81) | 12 (75.00) | ||
| Vasoconstrictors (dopamine drugs) | 0.478 | 0.489 | ||
| No | 122 (90.37) | 13 (81.25) | ||
| Yes | 13 (9.63) | 3 (18.75) | ||
| Special treatment (cast, stent, traction, restraint) | 0.000 | 1.000 | ||
| No | 130 (96.30) | 15 (100.00) | ||
| Yes | 5 (3.70) | 0 (0.00) | ||
| Deep vein catheterization | 2.158 | 0.340 | ||
| PICC | 17 (12.59) | 1 (6.25) | 0.110 | 0.740 |
| CVC | 107 (79.26) | 15 (93.75) | 1.115 | 0.291 |
| Infusion port | 11 (8.15) | 0 (0.00) | 0.458 | 0.498 |
| ICU stay | 0.579 | 0.447 | ||
| No | 128 (95.52) | 14 (87.50) | ||
| Yes | 6 (4.48) | 2 (12.50) | ||
| Preoperative presence of the following diseases | ||||
| No | 93 (68.89) | 7 (43.75) | 4.042 | 0.044* |
| Hypertension | 28 (20.74) | 3 (18.75) | 0.000 | 1.000 |
| Diabetes | 15 (11.11) | 6 (37.50) | 6.262 | 0.012* |
| Coronary heart disease | 4 (2.96) | 0 (0.00) | 0.000 | 1.000 |
| Gout | 3 (2.22) | 0 (0.00) | 0.000 | 1.000 |
| Chronic renal failure | 2 (1.48) | 0 (0.00) | 0.000 | 1.000 |
| Carcinoma | 3 (2.22) | 1 (6.25) | 0.016 | 0.900 |
| Viral hepatitis | 3 (2.22) | 1 (6.25) | 0.016 | 0.900 |
| Artificial expansion of anus | 2.094 | 0.348 | ||
| No | 68 (50.37) | 5 (31.25) | ||
| Yes | 67 (49.63) | 11 (68.75) | ||
| Gastrointestinal decompression | 0.233 | 0.629 | ||
| No | 116 (85.93) | 15 (93.75) | ||
| Yes | 19 (14.07) | 1 (6.25) | ||
| Oral lubricant guide and drainage | 0.457 | 0.499 | ||
| No | 94 (69.63) | 13 (81.25) | ||
| Yes | 41 (30.37) | 3 (18.75) | ||
| Passive muscle massage (intermittent pneumatic compression) | 2.911 | 0.088* | ||
| No | 22 (16.42) | 6 (37.50) | ||
| Yes | 112 (83.58) | 10 (62.50) | ||
| Time (intermittent pneumatic compression) | 0.388 | 0.824 | ||
| 90.00 | 93 (69.92) | 11 (73.33) | 0.000 | 1.000 |
| 90–<180 | 24 (18.05) | 3 (20.00) | 0.000 | 1.000 |
| 180.00 | 16 (12.03) | 1 (6.67) | 0.036 | 0.849 |
| Activity level on the first postoperative day | 5.149 | 0.161 | ||
| No | 28 (20.74) | 4 (25.00) | 0.005 | 0.944 |
| Low | 62 (45.93) | 11 (68.75) | 2.984 | 0.084* |
| Moderate | 38 (28.15) | 1 (6.25) | 2.529 | 0.112* |
| High | 7 (5.19) | 0 (0.00) | 0.092 | 0.761 |
The univariate analysis methods included the T test and chi-square test; the T test was used for age and the chi-square test was used for other factors.*P < 0.25.
DVT, deep vein thrombosis; BMI, body mass index; PICC, peripherally inserted central venous catheter; CVC, central venous catheter; ICU, intensive care unit.
Multivariate analysis.
| Factors | B | Sb | Wald | OR | 95% CI for OR | P |
|---|---|---|---|---|---|---|
| Age | 0.158 | 0.054 | 8.561 | 1.171 | 1.054–1.302 | 0.003* |
| BMI (18.5–23.9) | 2.104 | 0.965 | 4.756 | 8.199 | 1.237–54.329 | 0.029* |
| Hemostatic drugs (somatostatin, thrombin, etc.) | −2.407 | 0.840 | 8.216 | 0.090 | 0.017–0.467 | 0.004* |
| No preoperative disease | 1.230 | 1.085 | 1.284 | 3.420 | 0.408–28.683 | 0.257 |
| Preoperative diabetes | 1.087 | 1.123 | 0.936 | 2.964 | 0.328–26.782 | 0.333 |
| Passive muscle massage (intermittent pneumatic compression) | −2.416 | 0.939 | 6.622 | 0.089 | 0.014–0.562 | 0.010* |
| Low activity level | 1.856 | 1.016 | 3.336 | 6.398 | 0.873–46.877 | 0.068 |
| Moderate activity level | −1.929 | 1.419 | 1.847 | 0.145 | 0.009–2.345 | 0.174 |
| Constant | −13.936 | 5.832 | 5.711 | 0.000 | 0.017 |
Multivariate analysis means logistic multi-factor regression analysis.
*P < 0.05.
OR, odds ratio; 95%CI, 95% confidence interval; BMI, body mass index.
Figure 1.Evaluation of the prediction model – receiver operating characteristic (ROC) curves under the independent action of each factor. The area under the curve of each independent factor did not have high diagnostic efficiency. Sensitivity is on the horizontal axis, specificity on the vertical axis.
BMI, body mass index.
Figure 2.Evaluation of the prediction model – receiver operating characteristic (ROC) curves. Several variables were fitted to construct a new disease prediction model. The new model had high diagnostic efficiency. Sensitivity is on the horizontal axis, specificity on the vertical axis.
Figure 3.Evaluation of the prediction model – decision curve analysis (DCA). Compared with the single factor model, the area under the curve of the new model was significantly increased and had higher diagnostic efficiency. The curve of the new model was far away from the two sides of the coordinate axis, indicating high accuracy.
BMI, body mass index.
Cross-validation.
| Train AUC LOW | 0.770 |
| Train AUC | 0.872 |
| Train AUC UPPER | 0.974 |
| Test AUC LOW | 0.747 |
| Test AUC | 0.873 |
| Test AUC UPPER | 0.988 |
AUC, area under the curve.